Understanding how metabolic health affects survival in obesity-related cancers
Metabolic Obesity Phenotypes and Obesity-related Cancer Survival
This study is looking at how being overweight and having certain health issues can affect the survival of people with obesity-related cancers, aiming to find ways to tailor treatments to help them live longer and healthier lives.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-10975854 on NIH RePORTER |
What this research studies
This research investigates the relationship between metabolic health and survival outcomes in patients diagnosed with obesity-related cancers. It focuses on identifying different metabolic obesity phenotypes, which consider both obesity and metabolic dysfunction, to better understand their impact on cancer survival. By analyzing data from cancer patients, the study aims to uncover how metabolic health at the time of cancer diagnosis influences both cancer-specific and overall survival rates. This approach could lead to more personalized treatment strategies for patients with obesity-related cancers.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with obesity-related cancers who also exhibit signs of metabolic dysfunction.
Not a fit: Patients who do not have obesity-related cancers or those without any metabolic dysfunction may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved survival rates for patients with obesity-related cancers by tailoring treatments based on metabolic health.
How similar studies have performed: While there is emerging evidence on metabolic obesity phenotypes, this research is exploring a relatively novel approach in the context of cancer survival.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Winn, Maci — University of Utah
- Study coordinator: Winn, Maci
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.